Spots Global Cancer Trial Database for A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
Official Title: A Treatment Protocol For Patients With Gastrointestinal Stromal Tumor Who Are Ineligible For Participation In Other SU011248 Protocols And Are Refractory To Or Intolerant Of Imatinib Mesylate
Study ID: NCT00094029
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to permit access to SU011248 for treatment use by patients with GIST given the following conditions: a) patients undergo screening, but are not eligible for participation in ongoing clinical studies such as A6181004; AND b) patients have GIST which standard treatments have not been able to control with acceptable toxicity AND c) patients have the potential to derive clinical benefit from treatment with SU011248.
Detailed Description: Given that an Expanded Access study does not meet the definition of a controlled clinical investigation, and as such, is not considered an applicable drug clinical trial per NIH, Basic Results for such studies are not required to be reported. Protocol A6181036 has been identified as an Expanded Access trial, and has been registered to ClinicalTrials.gov, however Basic Results will not be posted.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Duarte, California, United States
Pfizer Investigational Site, Pasadena, California, United States
Pfizer Investigational Site, San Francisco, California, United States
Pfizer Investigational Site, Santa Monica, California, United States
Pfizer Investigational Site, Washington, District of Columbia, United States
Pfizer Investigational Site, Gainesville, Florida, United States
Pfizer Investigational Site, Gainsville, Florida, United States
Pfizer Investigational Site, Miami, Florida, United States
Pfizer Investigational Site, Tampa, Florida, United States
Pfizer Investigational Site, Niles, Illinois, United States
Pfizer Investigational Site, Park Ridge, Illinois, United States
Pfizer Investigational Site, Boston, Massachusetts, United States
Pfizer Investigational Site, New Bedford, Massachusetts, United States
Pfizer Investigational Site, Detroit, Michigan, United States
Pfizer Investigational Site, Detroit, Michigan, United States
Pfizer Investigational Site, Farmington Hills, Michigan, United States
Pfizer Investigational Site, Minneapolis, Minnesota, United States
Pfizer Investigational Site, Rochester, Minnesota, United States
Pfizer Investigational Site, Creve Coeur, Missouri, United States
Pfizer Investigational Site, St. Louis, Missouri, United States
Pfizer Investigational Site, St. Louis, Missouri, United States
Pfizer Investigational Site, Bronx, New York, United States
Pfizer Investigational Site, Buffalo, New York, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, Durham, North Carolina, United States
Pfizer Investigational Site, Portland, Oregon, United States
Pfizer Investigational Site, Portland, Oregon, United States
Pfizer Investigational Site, Dallas, Texas, United States
Pfizer Investigational Site, Seattle, Washington, United States
Pfizer Investigational Site, Seattle, Washington, United States
Pfizer Investigational Site, Madison, Wisconsin, United States
Pfizer Investigational Site, Burnos Aires, , Argentina
Pfizer Investigational Site, Camperdown, New South Wales, Australia
Pfizer Investigational Site, Randwick, New South Wales, Australia
Pfizer Investigational Site, Auchenflower, Queensland, Australia
Pfizer Investigational Site, Bedford Park, South Australia, Australia
Pfizer Investigational Site, East Melbourne, Victoria, Australia
Pfizer Investigational Site, Nedlands, Western Australia, Australia
Pfizer Investigational Site, Ashford SA, , Australia
Pfizer Investigational Site, Auchenflower QLD, , Australia
Pfizer Investigational Site, Graz, , Austria
Pfizer Investigational Site, Wien, , Austria
Pfizer Investigational Site, Brussels, , Belgium
Pfizer Investigational Site, Leuven, , Belgium
Pfizer Investigational Site, Calgary, Alberta, Canada
Pfizer Investigational Site, Vancouver, British Columbia, Canada
Pfizer Investigational Site, Winnipeg, Manitoba, Canada
Pfizer Investigational Site, St. John's, Newfoundland and Labrador, Canada
Pfizer Investigational Site, Toronto, Ontario, Canada
Pfizer Investigational Site, Montreal, Quebec, Canada
Pfizer Investigational Site, Santiago, RM, Chile
Pfizer Investigational Site, Bogota, Cundinamarca, Colombia
Pfizer Investigational Site, Brno, , Czech Republic
Pfizer Investigational Site, Praha 5, , Czech Republic
Pfizer Investigational Site, Aarhus C, , Denmark
Pfizer Investigational Site, Herlev, , Denmark
Pfizer Investigational Site, Helsinki, , Finland
Pfizer Investigational Site, Bordeaux Cedex, , France
Pfizer Investigational Site, Lyon, , France
Pfizer Investigational Site, Marseille, , France
Pfizer Investigational Site, Berlin, , Germany
Pfizer Investigational Site, Duesseldorf, , Germany
Pfizer Investigational Site, Koeln, , Germany
Pfizer Investigational Site, Muenchen, , Germany
Pfizer Investigational Site, Thessaloniki, , Greece
Pfizer Investigational Site, Happy Valley, , Hong Kong
Pfizer Investigational Site, Hong Kong, , Hong Kong
Pfizer Investigational Site, Budapest, , Hungary
Pfizer Investigational Site, New Delhi, Delhi, India
Pfizer Investigational Site, Mumbai, Maharashtra, India
Pfizer Investigational Site, Vellore, Tamil Nadu, India
Pfizer Investigational Site, Tel Hashomer, , Israel
Pfizer Investigational Site, Tel-Aviv, , Israel
Pfizer Investigational Site, Aviano (PN), , Italy
Pfizer Investigational Site, Aviano, PN, , Italy
Pfizer Investigational Site, Bologna, , Italy
Pfizer Investigational Site, Candiolo (TO), , Italy
Pfizer Investigational Site, Genova, , Italy
Pfizer Investigational Site, Milano, , Italy
Pfizer Investigational Site, Milano, , Italy
Pfizer Investigational Site, Milano, , Italy
Pfizer Investigational Site, Torino, , Italy
Pfizer Investigational Site, Seoul, , Korea, Republic of
Pfizer Investigational Site, Seoul, , Korea, Republic of
Pfizer Investigational Site, Mexico, DF, Mexico
Pfizer Investigational Site, Guadalajara, Jalisco, Mexico
Pfizer Investigational Site, Groningen, Gr, Netherlands
Pfizer Investigational Site, Leiden, , Netherlands
Pfizer Investigational Site, Oslo, , Norway
Pfizer Investigational Site, Warszawa, , Poland
Pfizer Investigational Site, Singapore, , Singapore
Pfizer Investigational Site, Singapore, , Singapore
Pfizer Investigational Site, Bratislava, , Slovakia
Pfizer Investigational Site, Oviedo, Asturias, Spain
Pfizer Investigational Site, L'Hospitalet de Llobregat, Barcelona, Spain
Pfizer Investigational Site, Barcelona, , Spain
Pfizer Investigational Site, Madrid, , Spain
Pfizer Investigational Site, Sevilla, , Spain
Pfizer Investigational Site, Valencia, , Spain
Pfizer Investigational Site, Göteborg, , Sweden
Pfizer Investigational Site, Lausanne, , Switzerland
Pfizer Investigational Site, Kaohsiung Hsien, , Taiwan
Pfizer Investigational Site, Taipei, , Taiwan
Pfizer Investigational Site, Taipei, , Taiwan
Pfizer Investigational Site, Taipei, , Taiwan
Pfizer Investigational Site, Ratchatawi, Bangkok, Thailand
Pfizer Investigational Site, Bangkok, , Thailand
Pfizer Investigational Site, Ankara, , Turkey
Pfizer Investigational Site, Inciralti / IZMIR, , Turkey
Pfizer Investigational Site, Istanbul, , Turkey
Pfizer Investigational Site, Leeds, England, United Kingdom
Pfizer Investigational Site, London, , United Kingdom
Pfizer Investigational Site, London, , United Kingdom
Pfizer Investigational Site, Manchester, , United Kingdom
Pfizer Investigational Site, Newcastle upon Tyne, , United Kingdom
Pfizer Investigational Site, Newcastle-Upon-Tyne, , United Kingdom
Pfizer Investigational Site, Caracas, Distrito Capital, Venezuela
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
